This market snapshot provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.
This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- ABK Biomedical
- Arsenal Medical
- Boston Scientific
- Cook
- Cordis/Cardinal Health
- Instylla
- Medtronic
- Merit Medical
- Ned Medical
- Obsidio
- SirTex Medical
- Stryker
- Terumo
- Varian
